Facebook Linkedin Twitter
Inside Precision Medicine Disruption of Asxl1 Gene Improves Tumor Control in Immunotherapy

Genitourinary cancer

T-Cells
News & Features

Disruption of Asxl1 Gene Improves Tumor Control in Immunotherapy

0
Artistic conceptualization of chromosomal DNA breakdown and extrachromosomal circular DNA (ecDNA). These ecDNA circles can drive resistance to therapy in bladder cancer. Credit: Ella Maru Studio, Inc
News & Features

Antiviral Enzymes Implicated in Bladder Cancer

0
Female nurse holding blood collection tubes for liquid biopsy
Molecular Dx

Blood Test Predicts Outcomes in Newly Diagnosed Metastatic Prostate Cancer

Laura Cowen
0
Three strands of DNA
News & Features

Expanding the Focus of Precision Medicine from Treatment to Prevention by Surya Singh

Surya Singh, MD
0
Prostate cancer stages. ancerous cells, malignant tumor compresses urethra. Pathological disruption, genital reproductive system anatomy, bladder Oncological or Urological Disease, bph, 3d render
Molecular Dx

Veracyte’s RNA Genetic Test Predicts Black Men’s Aggressive Prostate Cancer

Jonathan D. Grinstein, PhD
0
Prostate cancer cells, illustration
News & Features

CRISPR Barcoding Technology Maps the Spread of Prostate Cancer

0
Illustration showing prostate cancer
Molecular Dx

Some Men with Prostate Cancer Can Benefit from Immunotherapy

0
hand, holding pathology slides stained with leishman stain, displayed and ready for microscopy.
News & Features

New AI Model Enhances Cancer Diagnostics through Virtual Staining

0
Prostate cancer, illustration
News & Features

NSD2 Protein Flips Normal Androgen-Receptor Function Leading to Prostate Cancer

0
Illustration of the prostate organ in blue surrounded by red cancer cells to symbolize prostate cancer
News & Features

Opportunistic PSA Testing Drives European Prostate Cancer Overdiagnosis

0
123...27Page 1 of 27

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine